333 related articles for article (PubMed ID: 27085262)
41. The Boston keratoprosthesis in Stevens-Johnson syndrome.
Sayegh RR; Ang LP; Foster CS; Dohlman CH
Am J Ophthalmol; 2008 Mar; 145(3):438-44. PubMed ID: 18207122
[TBL] [Abstract][Full Text] [Related]
42. Medium-term outcomes of boston type 1 keratoprosthesis implantation in Bangkok, Thailand.
Lekhanont K; Thaweesit P; Muntham D; Chuckpaiwong V; Vongthongsri A
Cornea; 2014 Dec; 33(12):1312-9. PubMed ID: 25285588
[TBL] [Abstract][Full Text] [Related]
43. Boston type 1 keratoprosthesis combined with silicone oil for treatment of hypotony in prephthisical eyes.
Chan CC; Holland EJ; Sawyer WI; Neff KD; Petersen MR; Riemann CD
Cornea; 2011 Oct; 30(10):1105-9. PubMed ID: 21642848
[TBL] [Abstract][Full Text] [Related]
44. Anatomical survival and visual prognosis of Boston type I keratoprosthesis in challenging cases.
de la Paz MF; Stoiber J; de Rezende Couto Nascimento V; de Toledo JA; Seyeddain O; Hitzl W; Grabner G; Barraquer RI; Michael R
Graefes Arch Clin Exp Ophthalmol; 2014 Jan; 252(1):83-90. PubMed ID: 24390466
[TBL] [Abstract][Full Text] [Related]
45. Glaucoma Risk Factors and Outcomes Following Boston Keratoprosthesis Type 1 Surgery.
Geoffrion D; Harissi-Dagher M
Am J Ophthalmol; 2021 Jun; 226():56-67. PubMed ID: 33493469
[TBL] [Abstract][Full Text] [Related]
46. Glaucoma Management in Patients With Aniridia and Boston Type 1 Keratoprosthesis.
Nascimento E Silva R; Shen LQ; Chiou CA; Shanbhag SS; Paschalis EI; Pasquale LR; Colby KA; Dohlman CH; Chodosh J; Alves MR
Am J Ophthalmol; 2019 Nov; 207():258-267. PubMed ID: 31247168
[TBL] [Abstract][Full Text] [Related]
47. No Light Perception Outcomes Following Boston Keratoprosthesis Type 1 Surgery.
Muzychuk AK; Durr GM; Shine JJ; Robert MC; Harissi-Dagher M
Am J Ophthalmol; 2017 Sep; 181():46-54. PubMed ID: 28662941
[TBL] [Abstract][Full Text] [Related]
48. Boston keratoprosthesis type I in the elderly.
Homayounfar G; Grassi CM; Al-Moujahed A; Colby KA; Dohlman CH; Chodosh J
Br J Ophthalmol; 2017 Apr; 101(4):514-518. PubMed ID: 27381593
[TBL] [Abstract][Full Text] [Related]
49. Keratoprostheses in silicone oil-filled eyes: long-term outcomes.
Iyer G; Srinivasan B; Agarwal S; Pattanaik R; Rishi E; Rishi P; Shanmugasundaram S; Natarajan V
Br J Ophthalmol; 2019 Jun; 103(6):781-788. PubMed ID: 30021817
[TBL] [Abstract][Full Text] [Related]
50. [Boston-keratoprosthesis : Preliminary experiences in 13 high-risk eyes from the Department of Ophthalmology of the University of Cologne].
Schaub F; Hos D; Bucher F; Siebelmann S; Bachmann BO; Cursiefen C
Ophthalmologe; 2016 Jun; 113(6):492-9. PubMed ID: 26815458
[TBL] [Abstract][Full Text] [Related]
51. Boston keratoprosthesis for keratopathy in eyes with retained silicone oil: a new indication.
Iyer G; Srinivasan B; Gupta J; Rishi P; Sen PR; Bhende P; Gopal L; Padmanabhan P
Cornea; 2011 Oct; 30(10):1083-7. PubMed ID: 21705878
[TBL] [Abstract][Full Text] [Related]
52. Boston Type 1 Keratoprosthesis for Iridocorneal Endothelial Syndromes.
Phillips DL; Goins KM; Greiner MA; Alward WL; Kwon YH; Wagoner MD
Cornea; 2015 Nov; 34(11):1383-6. PubMed ID: 26398156
[TBL] [Abstract][Full Text] [Related]
53. Infectious keratitis after Boston type 1 keratoprosthesis implantation.
Chan CC; Holland EJ
Cornea; 2012 Oct; 31(10):1128-34. PubMed ID: 22960647
[TBL] [Abstract][Full Text] [Related]
54. Chronic hypotony associated with the Boston type 1 keratoprosthesis.
Dokey A; Ramulu PY; Utine CA; Tzu JH; Eberhart CG; Shan S; Gelhbach PL; Akpek EK
Am J Ophthalmol; 2012 Aug; 154(2):266-271.e1. PubMed ID: 22633347
[TBL] [Abstract][Full Text] [Related]
55. Outcomes of pars plana glaucoma drainage implant in Boston type 1 keratoprosthesis surgery.
Huh ES; Aref AA; Vajaranant TS; de la Cruz J; Chau FY; Cortina MS
J Glaucoma; 2014 Jan; 23(1):e39-44. PubMed ID: 24370810
[TBL] [Abstract][Full Text] [Related]
56. Clinical Outcomes Using Oversized Back Plates in Type I Boston Keratoprosthesis.
Kaufman AR; Cruzat A; Colby KA
Eye Contact Lens; 2018 Nov; 44(6):399-404. PubMed ID: 29219899
[TBL] [Abstract][Full Text] [Related]
57. Outcomes following Boston type 1 keratoprosthesis implantation in aniridia patients at the University of Montreal.
Hassanaly SI; Talajic JC; Harissi-Dagher M
Am J Ophthalmol; 2014 Aug; 158(2):270-276.e1. PubMed ID: 24844976
[TBL] [Abstract][Full Text] [Related]
58. Short-term visual outcomes of Boston type 1 keratoprosthesis implantation.
Dunlap K; Chak G; Aquavella JV; Myrowitz E; Utine CA; Akpek E
Ophthalmology; 2010 Apr; 117(4):687-92. PubMed ID: 20096462
[TBL] [Abstract][Full Text] [Related]
59. VITREORETINAL COMPLICATIONS IN EYES WITH BOSTON KERATOPROSTHESIS TYPE I.
Rishi P; Rishi E; Koundanya VV; Mathur G; Iyer G; Srinivasan B
Retina; 2016 Mar; 36(3):603-10. PubMed ID: 26398693
[TBL] [Abstract][Full Text] [Related]
60. Outcomes of Boston keratoprosthesis type 1 reimplantation: multicentre study results.
Wang JC; Rudnisky CJ; Belin MW; Ciolino JB;
Can J Ophthalmol; 2018 Jun; 53(3):284-290. PubMed ID: 29784167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
